title: Inotropic drugs for the treatment of heart failure.
authors.forename: D M
authors.initials: DM
authors.lastname: Mancini
authors.forename: G
authors.initials: G
authors.lastname: Keren
authors.forename: K
authors.initials: K
authors.lastname: Aogaichi
authors.forename: T H
authors.initials: TH
authors.lastname: LeJemtel
authors.forename: E H
authors.initials: EH
authors.lastname: Sonnenblick
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D002118:Calcium / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000494:pharmacology; D005934:Glucagon / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006632:Histamine / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D009200:Myocardial Contraction / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D014970:Xanthines / Q000627:therapeutic use
chemical_list: D000316:Adrenergic alpha-Agonists; D002316:Cardiotonic Agents; D002395:Catecholamines; D014970:Xanthines; D006632:Histamine; D005934:Glucagon; D002118:Calcium